Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Aim: To quantify the inhibition of HBV replication by targeted ribonuclease by using real-rime fluorescent PCR. Methods: Targeted ribonuclease was introduced into 2.2.15 cells by liposome-mediated transfection or HIV-TAT mediated protein transduction, Forty-eight hours after the transfection and 24 h after the transduction, supernatants of 2.2.15 cells were collected and HBV DNA in the supernatants was quantified by real-time fluorescent PCR with a commercial kit. Results: HBV DNA concentrations in the supernatants of 2.2.15 cells transfected or transducted with targeted ribonuclease were 4.9±2.4×108 copies/L and 8.3±4.0×108 copies/L, respectively. Compared with controls, transfection or transduction of targeted ribonuclease reduced HBV DNA concentration in the supernatants of 2.2.15 cells by 90.4% and 90.1%, respectively (P<0.05). Conclusion: Targeted ribonuclease can inhibit HBV replication in 2.2.15 cells. Copyright © 2004 by The WJG Press.

Cite

CITATION STYLE

APA

Liu, J., Li, Y. H., Ding, J., Gong, W. G., Xue, C. F., Zhao, Y., & Huang, Y. X. (2004). Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR. World Journal of Gastroenterology, 10(19), 2883–2885. https://doi.org/10.3748/wjg.v10.i19.2883

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free